Phenotypic switching has been described in several strains of Cryptococcus neoformans. It occurs in vivo during chronic infection and is associated with differential gene expression and changes in virulence. The switch involves changes in the polysaccharide capsule and cell wall that affect the yeast's ability to resist phagocytosis. In addition, the phenotypic switch variants elicit qualitatively different inflammatory responses in the host. The host's immune response ultimately affects selection of the switch variants in animal models of chronic cryptococcosis. The biological relevance of phenotypic switching is demonstrated in several murine infection models and further underlines the importance of phenotypic switching in the setting of human disease. This includes the association of switching and poor outcome in chronic infection, the ability of the mucoid variant of strain RC-2 (RC-2 MC) but not the smooth variant (RC-2 SM) to promote increased intracranial pressure in a rat model, and lastly the observation that antifungal interventions can promote the selection of more virulent switch variants during chronic murine infection.
Introduction
Phenotypic switching has been observed in pro-and eukaryotic microbes, including pathogenic fungi. It enables microorganisms to undergo rapid microevolution and to adapt to a constantly changing microenvironment (Silverman et al., 1979; Slutsky et al., 1985; Hammerschmidt et al., 1996; Lysnynansky et al., 1996; Schwan & Hinnebush, 1998) . For fungi, phenotypic switching was first described 20 years ago in Candida albicans (Slutsky et al., 1985 (Slutsky et al., , 1987 and the underlying molecular mechanisms have since been extensively studied (Perez-Martin & Uria, 1999; Miller & Johnson, 2002) . In more recent years, phenotypic switching has also been demonstrated in other fungi including Cryptococcus neoformans (Goldman et al., 1998; Fries et al., 1999 Fries et al., , 2001 Kugler et al., 2000; Lachke et al., 2000; Sinha et al., 2000) . Phenotypic switching in fungi is defined as the spontaneous emergence of colonies with altered colony morphology at rates higher than the somatic mutation rates (Soll, 1992) . Changes in colony morphology are associated with a diverse array of changes on the cellular level. Phenotypic switching constitutes one of several mechanisms by which a microbial population can diversify and achieve 'phenotypic heterogeneity'. Phenotypic switching is reversible and thus a controlled process, which is different from a random point mutation. Switching frequencies in fungi range between 10 À2 and 10 À5 and are higher than the expected frequency of spontaneous mutations, which in eukaryotes is between 10 À7 and 10 À8 mutations per generation. Phenotypic switching should also be differentiated from mass conversion, which represents a phenotype change in the entire pathogen population, whereas switching occurs only in a small proportion of the pathogen population, and hence selection pressure is required to change the dominance of a particular phenotype within a pathogen population. For human pathogens, the host represents a microenvironment of particular interest and a sophisticated immune response constitutes a dynamic selection pressure on a pathogen population. Therefore, phenotypic switching within a host will often affect the host-pathogen relationship with consequences that can translate into changes in virulence of the pathogen. An example of how phenotypic switching can alter the host-pathogen relationship is provided by Trypanosoma cruzi, where phenotypic switching generates antigenically different variants that can escape recognition by specific antibodies (Myler et al., 1984) . Other examples come from encapsulated bacteria, where phenotypic phase variation occurs and controls the expression of the microbial capsule. This process is pivotal in determining whether the microorganism is a commensal or an invasive pathogen (Swartley et al., 1997) .
Most fungal infections are chronic and therefore there is ample time for the pathogen population to change and evade the immune response. Because it is difficult to examine a pathogen population in vivo, studies addressing the phenotypic diversity of an isogenic population are difficult to undertake (Ebert, 1998) . In this review, we present findings on phenotypic switching of the human pathogen C. neoformans during chronic infection. We attempt to demonstrate why C. neoformans represents an ideal model to examine the effects of phenotypic switching during chronic infection on host-pathogen interaction.
Microevolution and phenotype variability during chronic cryptococcosis
Cryptococcus neoformans is an encapsulated yeast that causes chronic life-threatening infections in patients with AIDS. Chronic meningoencephalitis is the most common clinical presentation in this patient population and when untreated has a high morbidity and mortality rate. Although the annual incidence of cryptococcosis in the USA has decreased since the introduction of effective retroviral therapy (Mirza et al., 2003) , chronic cryptococcosis still constitutes a major opportunistic infection in Africa and in other less developed parts of the world where it affects up to 40% of AIDS patients (Perfect & Casadevall, 2002) . Cryptococcal meningoencephalitis is difficult to treat, despite effective antifungal therapy (Powderly, 2000) . Treatment failures in patients with chronic cryptococcosis are generally not the result of acquired drug resistance but represent persistence of the initial strain (Spitzer et al., 1993; Brandt et al., , 2001 Pfaller et al., 1999) . Lifelong suppressive antifungal therapy is recommended to reduce the likelihood of recurrent cryptococcosis in AIDS patients in whom the underlying HIV disease cannot be successfully suppressed.
The propensity of C. neoformans to undergo rapid changes in vitro and in vivo is referred to as 'microevolution'. Microevolution produces phenotypic variability that can alter the virulence of the pathogen. For C. neoformans strain 24067, analysis of different isolates maintained in different laboratories has revealed striking differences in phenotypic characteristics and virulence Chen & Casadevall, 1999) . Several observations support the concept that microevolution of C. neoformans also occurs during the course of human infection and contributes to persistence of infection: (1) serial C. neoformans isolates from chronically infected HIV-positive patients demonstrated differences in murine infection models as well as changes in the polysaccharide capsule (Cherniak et al., 1995; Jain, 2005) ; (2) investigations in chronic murine infection models have documented the emergence of both giant cells and poorly encapsulated forms (Feldmesser et al., 2001) ; (3) the emergence of variants that exhibit changes of the sterol content in the cell membrane has been demonstrated (Currie et al., 1995) ; and (4) changes in colony morphology and karyotype pattern occur during chronic infection (Fries et al., 1996; Sukroongreung et al., 2001) . In addition, careful analysis of primary clinical specimens has shown that phenotypic variation in colony morphology can be observed in isolates from the spinal fluid . In summary, many studies demonstrate that phenotypic changes occur rapidly during chronic infection.
Phenotypic switching of Cryptococcus neoformans strains
Phenotypic switching in Cryptococcus neoformans has thus far been described in serotype A (SB-4, J32) and D strains (24067a, RC-2) (summarized in Table 1 ). Most recently it has also been observed in the sibling species C. neoformans var. gattii (Jain, 2005) . In these strains colonies with altered morphology arise spontaneously at a frequency of about 1 in 10 À4 -10 À5 , and reversion to the parent smooth colony type occurs at a comparable frequency (c. 1 in 10 À3 -10 À5 ). The smooth colonies (S and SM) of both SB-4 and 24 067 are round with a smooth domed surface and smooth edges. The mucoid (M and MC) colonies are round with smooth edges and a shiny and mucoid-like colony surface. Wrinkled (WR), serrated (C) and pseudohyphal (PH) colonies exhibit an irregular domed surface with or without serrated margins. Both smooth and mucoid colonies represent standard colony types common to many C. neoformans strains, whereas the WR, C and PH colony types of strains SB-4 and 24067A are rarely observed in clinical isolates. This review focuses on strain RC-2 because it is the most thoroughly examined switching system to date.
Smooth to mucoid switching in Cryptococcus neoformans strain RC-2
This mucoid colony morphology is the result of excessive production of a viscous exopolysaccharide, which is secreted on the colony surface and gives them their shiny appearance ( Fig. 1 ). MC colonies of strain RC-2 exhibit a colony microarchitecture indistinguishable from that of the parent SM colony types. Careful analysis of newly generated MC switch variants demonstrates that phenotypic characteristics other than colony morphology are also changed ( Table 2 ). The MC switch variant grows more slowly and exhibits a larger polysaccharide capsule than the SM parent strain. In older MC colonies the capsular exopolysaccharide is abundantly shed. In addition, the MC switch variant of RC-2 exhibits increased sensitivity to lysing enzyme compared with the SM parent.
Does phenotypic switching of Cryptococcus neoformans truly occur in vivo?
Careful analysis of primary Cryptococcus neoformans isolates has demonstrated that both mucoid and smooth colonies can be detected in primary spinal fluid specimens from humans . It is difficult to demonstrate that switching actually occurs in the host during chronic infection because most experimental infections require infectious doses that are higher than the switching rate (10 À2 -10 À5 ). As a result, it is difficult to exclude the possibility that the emergence of new phenotypes in vivo is not the result of in vivo selection of more virulent phenotypes, derived from a mixed inoculum (Ebert, 1998) . Two features of the pathogen C. neoformans allowed us to prove that switching occurred in vivo: (1) the ability to induce progressive infection with a relatively small inoculum and (2) the fact that infections are often chronic and are lethal to the host only after a prolonged period of infection. By infecting many mice simultaneously with a small inoculum (10 3 SM cells), and applying the Poisson formula, we were able confidently to exclude the possibility (P = 1.1 Â 10
À12
) of a mixed infection as the cause for recovery of MC colony types after infection with SM (Fig.  2) . This result provided the first unequivocal evidence that phenotypic switching occurs during the course of chronic cryptococcosis (Fries et al., 2001) .
Phenotypic switch variants exhibit altered virulence in animal infection models
In all the 'switching' Cryptococcus neoformans strains studied so far, phenotypic switching results in variants that exhibit altered virulence in murine or rat infection models (Table  1) . RC-2-MC is consistently more virulent than RC-2-SM in intratracheal (i.t.) infection models in mice and rats, in an intravenous (i.v.) infection model in mice and in an intracisternal (i.c.) infection model in rats (Fig. 3) . RC-2-MC elicits an immune response strikingly different from that of RC-2-SM. In a pulmonary infection model in the mouse this strain elicits a more vigorous, macrophage-and neutrophil-dominated inflammatory response, associated with altered cytokine and chemokine expression profiles. Specifically the chemokines MCP and MIP-1a were upregulated in MC-infected mice whereas the cytokines interleukin-4 (IL-4), IL-10, IL-2, and tumour necrosis factor a (TNFa) were down-regulated compared with RC-2-SMinfected mice (Fries et al., 2001) . By contrast, RC-2-SM elicits an effective lymphocyte-dominated immune response that promotes clearance of the fungal infection. The damage-driven inflammatory response in MC-infected mice leads to lung damage and rapid death. Of note is that differences in cytokine response were also observed in peripheral blood cells of patients who were infected with RC-2-MC and RC-2-SM (Pietrella et al., 2003) .
Mechanisms of enhanced virulence and changes of the capsular polysaccharide
One unique characteristic of Cryptococcus neoformans is its thick polysaccharide capsule (Bulmer & Sans, 1968; Levitz et al., 1999; Feldmesser et al., 2000; Steenbergen et al., 2001) . Cryptococcus neoformans is a facultative intracellular pathogen and its polysaccharide capsule prevents phagocytosis and rapid destruction by macrophages. Glucuronoxylomannan (GXM) is the predominant capsular polysaccharide and is composed of (1 ! 3)-linked linear a-D-mannopyranan with b-D-xylopyranosyl (Xylp) and b-D-glucupyranosyluronic acid (GlcpA) residues added to the mannose at various positions. Six structural reporter groups (SRGs) are defined based on the amount of 2-0-linked, 4-0-linked Xylp residues, and 2-0-linked GlcpA residues .
Phenotypic switching in RC-2 alters the biophysical and biochemical properties of GXM (Fries et al., 2001) . The MC GXM of the RC-2 strain is more viscous than the GXM of the SM parent. MC GXM spins down faster during ultracentrifugation and is eluted off a size exclusion column earlier than SM GXM (Fig. 4, upper panel) . By using nuclear magnetic resonance analysis, however, the SM and MC GXM exhibit the same average biochemical repeat structure. Thus, it is not known what mediates the apparent difference between SM and MC GXM. Most importantly, in vitro and in vivo assays have established that the MC GXM is more potent in inhibiting phagocytosis by macrophages and thus contributes to the enhanced virulence of the MC switch variant in the RC-2 strain (Fig. 4, centre panel) . In addition, animal studies have suggested that the MC GXM accumulates in the cerebrospinal fluid (CSF) and in the meninges of rats that were infected by i.c. injection with a small inoculum of RC-2-MC . Fig. 2 . Schema comparing two scenarios that can lead to emergence of mucoid phenotypic switch variants (star) when the mouse is infected with a switching smooth strain (circle). The upper panel shows selection after infection with a mixed inoculum. The lower panel shows infection with a homogeneous pathogen population, switching in vivo and selection of the virulent variant. The P-value reflects the Poisson probability of finding one mucoid cell in a inoculum of 10 3 smooth cells if the switching frequency is 5%. Of note is that in C. neoformans strains SB-4 and 24 067a phenotypic switching resulted in significant changes of the biochemical composition of GXM (Fries et al., 1999) . The GXMs of the C colony type of SB-4 are composed of mixtures of SRGs (M2 and M3 for C) whereas SB-4-SM exhibits predominately SRG M2. In a similar fashion, the PH and WR colonies of 24 067a exhibit a mix of SRGs (M1 and M5), whereas the SM parents are predominately M1 and M2. The addition of an Xylp group at the 4-0 position in M3 and M5 most likely requires a different enzyme than linkage to the 2-0 position. Interestingly, M3 SRGs are traditionally thought to be present only in the GXM of C. neoformans var. gattii isolates (serotypes B and C) and not in GXM of C. neoformans var. neoformans isolates (serotypes A and D) (Fig. 4, lower panel) .
Thus, as in other encapsulated pathogens, phenotypic switching affects the polysaccharide capsule.
The biological relevance of phenotypic switching during chronic infection Phenotypic switching alters outcome
The biological relevance of phenotypic switching from SM to MC in chronic infection was established in several independent studies (Fig. 5) . Cryptococcosis in humans manifests as a chronic disease that is associated with significant morbidity and mortality despite potent therapy. In a murine model for chronic cryptococcal infection it was shown that the occurrence of phenotypic switching is associated with lethal outcome in murine infection. For this experiment, Balb/C mice (n = 108) were infected with 10 4 SM cells, which switch in vitro at a rate of 0.5 in 10 4 colonies. This infectious dose is generally cleared within 3 months by Balb/C mice. Mice autopsied before the onset of symptomatic disease (o day 36) and long-term survivors had significantly (P o 0.001, ANOVA) fewer MC colonies than those autopsied at the time of death between days 42 and 140 (Fig. 5a ).
Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure Elevated intracranial pressure (ICP) is the leading cause of high morbidity and mortality in patients with chronic cryptococcosis. This complication is only seen in a subpopulation of patients, and is rather difficult to treat. It is not known how Cryptococcus neoformans strain characteristics affect the development of ICP. Recent studies have demonstrated that RC-2 MC but not the RC-2 SM variant is able to promote increased ICP in a rat model of cryptococcal meningitis (Fig. 5b) . As in human infection, high ICP was associated with high numbers of CFU in the CSF. Histological examination of brain tissue demonstrated accumulation of polysaccharide in the meningeal layers and submeningeal brain tissue. Hence, these studies suggest that C. neoformans strain characteristics that are altered by phenotypic switching can determine if ICP develops during chronic infection . Thus, as in Candida (Soll et al., 1989; Vargas et al., 2000; Soll, 2002) , phenotypic switching in C. neoformans can contribute to virulence during chronic human infection. 
Effects of antifungal interventions on the emergence of switch variants
Antifungal drug therapy with the help of a competent immune system can successfully clear C. neoformans infection in humans. Most interestingly, in mice infected with a switching strain (RC-2-SM), both antifungal drug therapy and administration of anticapsular monoclonal antibody promoted the emergence of RC-2-MC variants in chronic murine infection models (Fig. 5c) . In a different set of experiments it was demonstrated that amphotericin B treatment reduced fungal burden less effectively in RC-2-MCinfected than in RC-2-SM-infected mice. Consequently, amphotericin B treatment resulted in a more pronounced prolongation of survival in SM-infected compared with MC-infected mice (20 vs. 42 days, P o 0.05; data not shown). In addition, administration of anticapsular monoclonal antibody mediated better protection in SM-infected than MC-infected mice, although a protective effect was not consistently observed at all doses. Antifungal interventions did not enhance phenotypic switching per se. The clearance of switch variants by the immune response differed. With Fries et al., 2001) . (c) Recovery of MC switch variants was significantly increased at time of death in mice that were infected intratracheally with the SM variant and treated with anticapsular monoclonal antibody (AMB) at the time of infection compared with control-treated mice. MC variants were also increased after 10 doses of AMB compared with control mice (P = 0.032, Kruskal-Wallis test; error bar reflects standard error). Selection of MC variants was also observed when mice were infected with a mixed inoculum of SM and MC variants at a ratio of 999 : 1 and then treated with AMB (P = 0.04, t test; error bar reflects standard deviation) (modified from respect to human disease, this finding was important because it suggests that both chemotherapeutic and immunological antifungal interventions may promote the selection of the more virulent mucoid variant. These findings are important because they further our understanding of how phenotypic switching during chronic infection may affect the outcome of infection in chronically infected hosts . Because treatment affects selection in the host, phenotypic switching may contribute to the frequent treatment failures that are observed in immunosuppressed hosts.
Molecular mechanism of phenotypic switching
The molecular mechanisms mediating phenotypic switching in Cryptococcus neoformans are currently not understood. Phenotypic switching in some microbes can be achieved by genetic changes that follow a Mendelian inheritance pattern, whereas for other microbes the mechanisms are epigenetic and inherited in a non-Mendelian fashion (e.g. silencing). In Candida white-opaque switching and sexual mating are controlled by homeodomain proteins in the mating-type locus. In other microbes a variety of mechanisms have been implicated in generating phenotypic variability within a population, including transposition of mobile sequences, silencing of gene expression, activation of mutator genes and infection with prions, which modify the fidelity of translation termination (Chao et al., 1983; Martin et al., 1993; Deitsch et al., 1997; Perez-Martin & Uria, 1999; Lachke et al., 2000; True & Lindquist, 2000; Klar et al., 2001; Srikantha et al., 2001) .
Although karyotype instability was observed in strains 24067a and SB-4 (Goldman et al., 1998; Fries et al., 1999) , similar to the switching observed in Candida albicans strain 3153A, it could not consistently be correlated with phenotypic variability and was not reversible (Rustchenko-Bulgac, 1991; Soll, 1992; Perez-Martin & Uria, 1999) . Investigations involving differential display of RC-2-SM and RC-2-MC mRNA (RC-2 strain) demonstrated that phenotypic switching was associated with down-regulation of genes in the MC switch variant relative to the SM switch variant. The function of most of these genes is still unknown, but some may represent immunogenic epitopes (Guerrero et al., 2003) . Future studies are directed at determining the specific function of the individual genes.
Summary
The phenomenon of phenotypic switching has been described for many different types of pathogens, and it enables pathogens to adapt to a changing environment. Such environments include different hosts that will employ sophisticated immunological tools to rid themselves of the pathogen and variable environmental niches where microbes can be subjected to many types of selection pressure. Virulence of a pathogen is dependent on the pathogen's interaction with the host, and thus may not be a fixed characteristic of the pathogen but the product of a complex interplay between the host and the pathogen (Casadevall & Pirofski, 1999 ). Changes of the host's immune competence as well as changes of the pathogen's virulence factors affect this complex relationship.
Cryptococcus neoformans is an excellent model organism to study phenotypic switching and its impact on progression of chronic infection. Data from our laboratory demonstrate for the first time phenotypic switching in a fungus during experimental infection (Fries et al., 2001) . The importance of this finding is underlined by the demonstration that the phenotypic switch changes the outcome of infection (D'Souza & Heitman, 2001 ) and that selection of switch variants is promoted in the setting of antifungal therapy. Cryptococcus neoformans is a haploid fungus that exhibits an asexual reproduction mode during human infection. Molecular studies suggest that C. neoformans populations have a largely clonal population structure that may have limited options for rapid change in response to environmental stress. In the setting of chronic infection, the limited virulence traits of C. neoformans may require constant microevolution to evade the immune response. We propose that phenotypic switching allows this pathogen to undergo a rapid change without the disadvantage of an increased mutation rate, thus avoiding the accumulation of disadvantageous mutations. Future studies will concentrate on elucidating the underlying mechanism for phenotypic switching, which may differ for the individual strains.
